Nifty
Sensex
:
:
24565.35
80599.91
-203.00 (-0.82%)
-585.67 (-0.72%)

Pharmaceuticals & Drugs

Rating :
68/99

BSE: 544067 | NSE: INNOVACAP

887.70
01-Aug-2025
  • Open
  • High
  • Low
  • Previous Close
  •  912.6
  •  912.6
  •  870.6
  •  909.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  60391
  •  53842465.3
  •  1260
  •  586.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,069.84
  • 39.53
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,337.75
  • N/A
  • 5.28

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.90%
  • 1.05%
  • 27.71%
  • FII
  • DII
  • Others
  • 0.23%
  • 12.24%
  • 7.87%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 24.81
  • 10.32

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 27.86
  • 10.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 30.03
  • 23.59

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
16.49
22.41
29.2
41.1
Revenue
1081
1244
1760
2211
EBITDA
154
257
347
Net Income
94
128
167
235
ROA
9.3
11.3
12.9
ROE
17.04
16
18.9
FCFF
-153
-43
158
FCFF Yield
-3.04
-0.85
3.13
Net Debt
158
-50
-218
BVPS
126.47
196.9
238

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
314.74
262.63
19.84%
316.46
302.49
4.62%
318.20
282.94
12.46%
294.27
0.00
0
Expenses
267.06
224.56
18.93%
269.90
257.89
4.66%
268.47
242.47
10.72%
252.09
0.00
0
EBITDA
47.69
38.08
25.24%
46.56
44.60
4.39%
49.73
40.48
22.85%
42.18
0.00
0
EBIDTM
15.15%
14.50%
14.71%
14.74%
15.63%
14.31%
14.33%
0.00%
Other Income
3.38
5.69
-40.60%
4.33
2.34
85.04%
2.22
3.34
-33.53%
2.12
0.00
0
Interest
1.95
0.81
140.74%
0.17
6.80
-97.50%
0.15
8.81
-98.30%
0.14
0.00
0
Depreciation
9.80
3.41
187.39%
5.13
4.93
4.06%
4.99
4.83
3.31%
4.85
0.00
0
PBT
39.31
39.55
-0.61%
45.59
35.20
29.52%
46.81
30.18
55.10%
39.31
0.00
0
Tax
9.74
10.82
-9.98%
11.38
10.07
13.01%
11.80
7.28
62.09%
9.83
0.00
0
PAT
29.57
28.72
2.96%
34.20
25.13
36.09%
35.00
22.91
52.77%
29.48
0.00
0
PATM
9.40%
10.94%
10.81%
8.31%
11.00%
8.10%
10.02%
0.00%
EPS
5.17
5.02
2.99%
5.98
4.39
36.22%
6.12
4.77
28.30%
5.15
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
-
1,243.68
1,081.31
926.38
800.53
410.66
Net Sales Growth
-
15.02%
16.72%
15.72%
94.94%
 
Cost Of Goods Sold
-
639.36
579.35
552.63
529.46
273.02
Gross Profit
-
604.32
501.96
373.76
271.07
137.65
GP Margin
-
48.59%
46.42%
40.35%
33.86%
33.52%
Total Expenditure
-
1,057.52
926.85
812.73
704.51
356.18
Power & Fuel Cost
-
27.14
20.39
9.51
7.91
5.48
% Of Sales
-
2.18%
1.89%
1.03%
0.99%
1.33%
Employee Cost
-
116.78
90.66
54.80
40.46
22.33
% Of Sales
-
9.39%
8.38%
5.92%
5.05%
5.44%
Manufacturing Exp.
-
207.40
177.68
152.24
100.72
43.28
% Of Sales
-
16.68%
16.43%
16.43%
12.58%
10.54%
General & Admin Exp.
-
36.83
32.63
23.39
15.22
8.59
% Of Sales
-
2.96%
3.02%
2.52%
1.90%
2.09%
Selling & Distn. Exp.
-
18.38
15.67
14.24
6.93
2.18
% Of Sales
-
1.48%
1.45%
1.54%
0.87%
0.53%
Miscellaneous Exp.
-
11.63
10.47
5.93
3.81
1.30
% Of Sales
-
0.94%
0.97%
0.64%
0.48%
0.32%
EBITDA
-
186.16
154.46
113.65
96.02
54.48
EBITDA Margin
-
14.97%
14.28%
12.27%
11.99%
13.27%
Other Income
-
12.04
12.49
9.20
2.88
1.37
Interest
-
2.40
21.46
19.97
5.68
3.93
Depreciation
-
24.78
15.96
11.08
7.50
5.59
PBT
-
171.02
129.53
91.80
85.72
46.34
Tax
-
42.76
35.18
23.84
21.77
11.84
Tax Rate
-
25.00%
27.16%
25.97%
25.40%
25.55%
PAT
-
128.26
94.34
67.95
63.95
34.50
PAT before Minority Interest
-
128.26
94.34
67.95
63.95
34.50
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
10.31%
8.72%
7.34%
7.99%
8.40%
PAT Growth
-
35.96%
38.84%
6.25%
85.36%
 
EPS
-
22.42
16.49
11.88
11.18
6.03

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
959.42
830.89
276.51
208.61
144.82
Share Capital
57.23
57.23
48.00
12.00
12.00
Total Reserves
902.19
773.67
228.51
196.61
132.82
Non-Current Liabilities
255.75
204.55
194.16
88.09
44.49
Secured Loans
243.55
208.20
62.34
40.36
6.00
Unsecured Loans
0.00
0.00
71.83
26.99
0.00
Long Term Provisions
9.90
9.14
46.82
18.23
36.09
Current Liabilities
376.44
293.98
277.55
315.47
215.15
Trade Payables
201.80
179.66
158.48
144.80
112.23
Other Current Liabilities
77.29
57.98
20.55
28.30
68.96
Short Term Borrowings
65.65
23.84
97.94
120.09
33.43
Short Term Provisions
31.69
32.50
0.58
22.27
0.53
Total Liabilities
1,591.61
1,329.42
748.22
612.17
404.46
Net Block
829.87
357.88
182.88
183.03
79.14
Gross Block
901.14
406.39
215.53
205.97
106.64
Accumulated Depreciation
71.27
48.51
32.65
22.93
27.50
Non Current Assets
865.06
721.17
305.75
212.17
134.01
Capital Work in Progress
22.52
340.79
21.54
0.03
7.26
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
6.82
22.00
101.07
28.82
47.60
Other Non Current Assets
5.85
0.50
0.26
0.28
0.00
Current Assets
719.12
608.25
442.47
400.00
270.46
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
207.99
144.02
117.32
128.39
91.44
Sundry Debtors
331.64
288.49
265.22
212.69
138.55
Cash & Bank
68.17
86.75
18.88
2.44
11.89
Other Current Assets
111.32
8.91
13.45
6.41
28.57
Short Term Loans & Adv.
78.10
80.08
27.61
50.08
26.05
Net Current Assets
342.69
314.27
164.92
84.53
55.31
Total Assets
1,584.18
1,329.42
748.22
612.17
404.47

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 21
Cash From Operating Activity
63.84
146.34
67.12
41.57
PBT
171.02
129.53
91.80
46.34
Adjustment
31.29
37.16
25.92
9.59
Changes in Working Capital
-114.75
7.31
-31.06
-1.14
Cash after chg. in Working capital
87.56
174.00
86.65
54.80
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-23.71
-27.66
-19.53
-13.23
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-151.59
-498.97
-90.84
-19.67
Net Fixed Assets
-171.71
-330.93
-113.42
Net Investments
0.00
0.00
-60.00
Others
20.12
-168.04
82.58
Cash from Financing Activity
91.53
360.83
27.09
-19.34
Net Cash Inflow / Outflow
3.79
8.20
3.37
2.56
Opening Cash & Equivalents
11.73
3.52
0.15
2.23
Closing Cash & Equivalent
15.52
11.73
3.52
4.80

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
167.66
145.20
57.61
43.46
30.17
ROA
8.78%
9.08%
9.99%
12.58%
10.48%
ROE
14.33%
17.04%
28.02%
36.19%
27.04%
ROCE
14.65%
19.06%
24.34%
30.64%
28.42%
Fixed Asset Turnover
1.94
3.48
4.46
5.17
4.09
Receivable days
89.43
93.25
92.78
79.30
100.13
Inventory Days
50.76
44.01
47.70
49.63
69.74
Payable days
108.88
106.52
100.16
88.60
122.96
Cash Conversion Cycle
31.30
30.74
40.32
40.33
46.92
Total Debt/Equity
0.35
0.29
0.85
0.95
0.31
Interest Cover
72.11
7.04
5.60
16.09
12.80

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.